644
Participants
Start Date
October 10, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Dalia Monitoring
All patients consulting psychiatrists and general practitioners in participating centers, meeting all eligibility criteria and agreeing to participate in the study, will be consecutively selected and randomized into one of the two groups. For iInterventional arm: Patients will benefit from Dalia telemonitoring, in addition to conventional care.
Conventional healthcare
All patients consulting psychiatrists and general practitioners in participating centers, meeting all eligibility criteria and agreeing to participate in the study, will be consecutively selected and randomized into one of the two groups. For Control arm: Patients in this group will benefit from the conventional care pathway.
Neurostim Luxembourg, Paris
Lead Sponsor
Dalia Care
INDUSTRY